🚀 VC round data is live in beta, check it out!
- Public Comps
- Odinwell
Odinwell Valuation Multiples
Discover revenue and EBITDA valuation multiples for Odinwell and similar public comparables like S2Medical, Momina Krepost, Audientes, Cuprina Holdings (Cayman) and more.
Odinwell Overview
About Odinwell
Odinwell AB is a medtech company with a patented optical technology for assessment of covered wounds.
Founded
N/A
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$700K
Odinwell Financials
Odinwell reported last fiscal year revenue of — and negative EBITDA of ($534K).
In the same fiscal year, Odinwell generated $423K in gross profit, ($534K) in EBITDA losses, and had net loss of ($621K).
Odinwell P&L
In the most recent fiscal year, Odinwell reported revenue of — and EBITDA of ($534K).
Odinwell expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | $423K | XXX | XXX | XXX |
| EBITDA | — | XXX | ($534K) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($621K) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Odinwell Stock Performance
Odinwell has current market cap of $1M, and enterprise value of $700K.
Market Cap Evolution
Odinwell's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $700K | $1M | 0.8% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOdinwell Valuation Multiples
Odinwell trades at (1.3x) EV/EBITDA.
Odinwell Financial Valuation Multiples
As of April 2, 2026, Odinwell has market cap of $1M and EV of $700K.
Equity research analysts estimate Odinwell's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Odinwell has a P/E ratio of (1.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV (current) | $700K | XXX | $700K | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.7x | XXX | XXX | XXX |
| P/E | — | XXX | (1.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Odinwell Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Odinwell Margins & Growth Rates
Odinwell's revenue in the last fiscal year grew by —.
Odinwell Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Odinwell Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| S2Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Momina Krepost | XXX | XXX | XXX | XXX | XXX | XXX |
| Audientes | XXX | XXX | XXX | XXX | XXX | XXX |
| Cuprina Holdings (Cayman) | XXX | XXX | XXX | XXX | XXX | XXX |
| Airway Medix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Odinwell M&A Activity
Odinwell acquired XXX companies to date.
Last acquisition by Odinwell was on XXXXXXXX, XXXXX. Odinwell acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Odinwell
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOdinwell Investment Activity
Odinwell invested in XXX companies to date.
Odinwell made its latest investment on XXXXXXXX, XXXXX. Odinwell invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Odinwell
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Odinwell
| Where is Odinwell headquartered? | Odinwell is headquartered in Sweden. |
| Is Odinwell publicly listed? | Yes, Odinwell is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Odinwell? | Odinwell trades under ODIN ticker. |
| When did Odinwell go public? | Odinwell went public in 2021. |
| Who are competitors of Odinwell? | Odinwell main competitors are S2Medical, Momina Krepost, Audientes, Cuprina Holdings (Cayman). |
| What is the current market cap of Odinwell? | Odinwell's current market cap is $1M. |
| Is Odinwell profitable? | No, Odinwell is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.